Company intelligence / Profile preview

CRB Inverbío

Ownership: Private
Employees: ~8
Development stage: Other

Overview

CRB Inverbío is a Spanish venture capital management firm specializing in early-stage investments in life sciences, including biotech, medtech, digital health, and medical technologies. They have invested and managed eleven biotech companies since 2005 and currently manage two main funds—Cross Road Biotech SCR (fully invested) and CRB Bio II—focusing on seed-stage spin-offs addressing unmet medical needs. Their current portfolio includes about thirteen innovative life science startups across diagnostics, therapeutics, personalized medicine, imaging technologies, wearables for cardiac monitoring, nanomechanical biosensing technology platforms for Alzheimer’s diagnosis and more.

Industry: Investors

Partnerships

The firm co-invests with other investors but no specific major pharma partnerships are listed. They often syndicate with other VCs or strategic partners at the company level

Beyond the preview

Go deeper on CRB Inverbío.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CRB Inverbío.

Explore the full profile